ArticleFrontiers in medicine2022

Complementing Tissue Testing With Plasma Mutation Profiling Improves Therapeutic Decision-Making for Patients With Lung Cancer.

Yukti Choudhury et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.